Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000523642 | SCV000617147 | uncertain significance | not provided | 2017-06-22 | criteria provided, single submitter | clinical testing | The M138I variant in the MPI gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. This variant is observed in 66/10,400 alleles (0.63%) from individuals of African background in the ExAC dataset (Lek et al., 2016). The M138I variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. In addition, this substitution occurs at a position where amino acids with similar properties to Methionine are tolerated across species, and Isoleucine is present in three mammalian species. However, in silico analysis predicts this variant is probably damaging to the protein structure/function. Missense variants in the same codon (M138T) and a nearby residue (I140T) have been reported in the Human Gene Mutation Database in association with CDG1B (Jaeken et al., 1998; Stenson et al., 2014), supporting the functional importance of this region of the protein. We therefore interpret M138I as a variant of uncertain significance. |
Invitae | RCV001083362 | SCV001005085 | likely benign | MPI-congenital disorder of glycosylation | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001821456 | SCV002065315 | likely benign | not specified | 2021-12-13 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001083362 | SCV001454926 | benign | MPI-congenital disorder of glycosylation | 2019-10-28 | no assertion criteria provided | clinical testing |